ClinicalTrials.govpublic full text
Efficacy and Safety of Twice Daily 60mg AZD9668 in COPD for 12 Weeks in Patients on Background Budesonide/Formoterol
chronic obstructive pulmonary disease (copd), chronic, obstructive, pulmonary, lung, respiratory disease, efficacy, placebo-controlled, copd, fev1, st georges respiratory questionnaire, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 887679
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.